Live Cell Tumor Profiling
Unlock The Secret to Personalized Cancer Treatment
Just like Superman’s weakness to Kryptonite, cancer cells have their own weakness: a specific chemo medicine that can potentially kill them. But here’s the catch – what works for one patient may not work for another, even if they have the same diagnosis.
Chemotherapeutic drug resistance is believed to cause treatment failure in over 90% of patients with metastatic cancer.
Source: Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol. 2005;205(2):275–92.
* Chemotherapeutic drug resistance, or multidrug resistance (MDR), occurs when cancer does not respond to repeated rounds of chemotherapy. This resistance develops because cancer cells can decrease the amount of chemotherapy drugs they take in and increase their ability to expel these drugs from the cell.
Thus, begs the question, with hundreds of chemo drugs and combinations available, how can oncologists know which ones will truly be effective? The truth is, they often can’t rely on clinical trials or insurance-approved options to provide the best results.
But there is hope.
Our team at ICCA Global has developed a groundbreaking approach: Live-Cell Tumor Profiling.
A vital pillar of FivePoints Cancer Care™, which has been clinically shown to often surpass conventional cancer treatments, with fewer side effects and far more favorable treatment outcomes!
By analyzing a small live tumor sample, we can determine with great certainty which chemo drugs or combinations will work best for each individual patient. No more guessing or wasting precious time on ineffective treatments.
This test not only identifies the most effective options, but it also saves patients from unnecessary costs and harmful side effects by ruling out treatments that won’t work. Our Live-Cell Tumor Profile studies have shown to increase patient outcomes by upwards of 200%!
It’s a game changer for patients who have struggled with finding the right chemo treatment. Say goodbye to guesswork and hello to a personalized, revolutionary cancer treatment plan.
“Conventional delivery of chemotherapeutic drugs has used a shotgun approach – flood the bloodstream with chemicals to attack all cancerous cells and hope that it leaves enough good cells behind to recover once bad cells are gone.” says Greg DiRienzo, CEO of ICCA Global (with most treatments undertaken at a state-of-the-art facility in Baja California, Tijuana Mexico, 15 minutes from San Diego, CA).
With FivePOINTS Cancer Care™, 95% or more absorption of its non-toxic medicines targeting both primary and secondary tumors, rendering them powerless to spread their cells through the bloodstream. Only killing tumor cells, not tumor cells, and does not reduce, but rather increases natural immune functions in the body.”
Don’t settle for one-size-fits-all treatment. Your fight against cancer just got a whole lot stronger. Learn more about how we treat cancer here.